Clinical Trial Update: The Food Effect on Pharmacokinetics of DA-302168S [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how food affects the pharmacokinetics of DA-302168S in individuals with overweight and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DA-302168S

Snippet

Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED